Condition: Coronary Artery Disease · Atherosclerotic Plaque · De Novo Stenosis · Sponsor: Korea University Ansan Hospital
This study aims to investigate whether DCB angioplasty, compared to statin-based medical treatment alone, will lead to more reduction in plaque lipid burden as assessed by near infrared spectroscopy (NIRS) at 6-9 months following the index procedure.
This description comes directly from the study's public registry record.
Sunwon Kim, MD, PhD · 82-31-8099-6349 · sunwon11@hanmail.net
Always discuss trial participation with your own doctor first.
| Korea University Ansan Hospital | Ansan-si, Gyeonggi-do, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05438121